Siemens, LabCorp Sign Diagnostic Co-Development Agreement | GenomeWeb
NEW YORK (GenomeWeb News) - Siemens Healthcare and Laboratory Corporation of America have agreed to "discuss future possibilities" to co-develop clinical diagnostic tests, the companies said today.
 
The non-exclusive agreement encompasses the areas of metabolic syndrome, oncology, diabetes, and companion diagnostics that are "designed to identify the suitability between patients and a particular drug therapy," the partners said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.